After FDA sign-off, Colorado's drug import plan faces tough road ahead on June 17, 2026 authorization Canadian Colorado Cost Savings drug import plan Drug Prescriptions Import supply chain United States Food and Drug Administration +
Ambrosia Biosciences Raises $100M Series B for Oral GLP-1 Drug Development on April 01, 2026 Ambrosia Biosciences Blue Owl Healthcare Clinical Trials Colorado Glucagon-Like Peptide 1 Oral cavity Series B funding small molecule therapy Weight Loss +